Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Interim Management Statement

9 Nov 2009 07:00

RNS Number : 1578C
Macfarlane Group PLC
09 November 2009
 



Interim Management Statement

9 November 2009

Macfarlane Group PLC, which includes the UK's leading packaging distribution business, today publishes its Interim Management Statement for the period from 30 June 2009 to date. As anticipated in the interim results announcement, the Group has recorded a stronger trading performance in the second half of 2009.

In Packaging Distribution, a continuing improvement in gross margins and an 8% reduction in overheads have led to marginally higher profitability relative to the same period in 2008. This improved performance has been achieved despite revenue in the division reducing by 6% and includes the benefit of the acquisition of Allpoint Packaging, which was acquired in the final quarter of 2008 and continues to trade well.

Manufacturing Operations' revenues are 12% below those seen at this point in 2008. We have already taken action to ensure that our cost base is aligned with these lower levels of demand. These actions together with operational momentum have ensured that both businesses in this division, Labels and Packaging Manufacturing, have traded profitably since 30 June 2009.

The performances referred to are after taking account of costs of £0.6m for the restructuring programme, which has had a considerable mitigating effect on the impact of the UK economic downturn.

Bank borrowings have reduced since 30 June 2009 and are expected to reduce further in the remainder of 2009, given the strong focus on working capital management.

Whilst recent rises on equity markets have improved investment values in the Group's final salary pension scheme, reductions in bond yields have offset this improvement. The Group has recently concluded an agreement with the pension scheme's trustees that annual contributions of £2.0m (previously £1.3m) will be made until the conclusion of the next actuarial valuation, due on 1 May 2011. The Group is committed to addressing the means by which the level of deficit and the volatility can be managed in future years.

Archie Hunter, Chairman of Macfarlane Group, said 

"Macfarlane Group has the business strength and momentum to deal with the current economic conditions. We have taken strong actions to reduce our cost base in line with current demand conditions and the Board remains confident that the results for 2009 will be in line with its expectations. Macfarlane Group remains well placed to benefit from the economic recovery when it emerges."

Further information: Archie S. Hunter Chairman 0141 333 9666

Peter D. Atkinson Chief Executive

John Love Finance Director

Callum Spreng  Spreng & Co 0141 229 0482

07803 970103

Notes to Editors:

Macfarlane Group PLC is a UK-based group of companies focused on packaging-related activities. The Packaging Distribution business is the leading UK distributor of a comprehensive range of packaging consumable products. The Manufacturing Operations comprise two businesses, the manufacture of transit packaging and the manufacture of self-adhesive and re-sealable labels. Headquartered in GlasgowScotland, Macfarlane Group employs 700 people at 22 sites, principally in the UK and Ireland, servicing 20,000+ customers, in a wide range of sectors including: consumer goods; logistics; electronics; food manufacturing and retailing; internet and home retailing.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUUGMWGUPBGMQ
Date   Source Headline
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021
25th Mar 20224:12 pmRNSDirector/PDMR Shareholding
11th Mar 20223:41 pmRNSDirector/PDMR Shareholding
24th Feb 20221:00 pmRNSDividend Payment Date
24th Feb 20227:00 amRNSFinal Results
11th Feb 20227:00 amRNSNotice of Results
4th Jan 20227:00 amRNSDisposal
25th Nov 20217:00 amRNSTrading Update
18th Nov 202110:17 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
6th Aug 20217:00 amRNSNotice of Interim Results
25th Jun 20214:41 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSResult of AGM
11th May 202112:00 pmRNSBoard Changes
11th May 202112:00 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.